<?xml version="1.0" encoding="UTF-8"?>
<p>For inhibited ROS production, MH treatment demonstrated the reduction of ROS production in dose-dependent manner comparing H
 <sub>2</sub>O
 <sub>2</sub> treatment (231.8% ± 17.6%) [
 <xref ref-type="fig" rid="F5">Figure 5</xref>]. Interestingly, the MH (133.7% ± 10.3%) has a similar effect comparing to hispidulin treatment (132.5% ± 10.6%). Taken together, the MH and hispidulin treatment alone did not show any negative effect in the neuronal cells.
</p>
